Summit Therapeutics Insider Trading Activity | NASDAQ:SMMT

Comments

Summit Therapeutics Inc Insider Trading Activity

SMMTNASDAQ

Trade with Public

$25.15

0.732.99%

At close: Apr 17, 5:00 PM EST

$25.19

0.040.16%

After Hours: Apr 17, 7:57 PM EST

Overview News Earnings Options Analyst RatingsInsider TradesShort Interest Stock Report

Summit Therapeutics Insider Trading Activity | NASDAQ:SMMT | Benzinga

Track the latest Summit Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Summit Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Summit Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Summit Therapeutics Inc

Shares Outstanding

775.373M

Shares Float

149360283.0%

Insider Shares Owned

220.960M

Insider Percentage Owned

29.8%

Institutional Shares Held

59.296M

Institutional Percentage Held

7.65%

Loading calendar...

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

SMMT Insider Trading News

PRO
Summit Therapeutics Form4 Filings From Late Thursday Show Co-CEOs Each Purchased 338,394 Shares At Avg. Price Of $17.69

Benzinga Newsdesk

Over $395M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying

The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying

U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades.

Lisa Levin

OncoCyte And 2 Other Stocks Under $1 Insiders Are Aggressively Buying

The Dow Jones dropped by around 170 points on Wednesday following the release of Fed minutes. Investors, meanwhile, focused on some notable insider trades.

Lisa Levin

Last Week's Notable Insider Buys: Activision, Avis Budget, Energy Transfer And More

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty or are near all-time highs. A couple of chief executive officers and an executive board chair were among the insiders buying shares this past week.

Nelson Hem

People Also Watch

BeOne Medicines Ltd

NASDAQ:ONC

$323.87

Neurocrine Biosciences Inc

NASDAQ:NBIX

$133.25

Ionis Pharmaceuticals Inc

United Therapeutics Corp

Summit Therapeutics Insider Trading Activity | NASDAQ:SMMT | Benzinga

Track the latest Summit Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Summit Therapeutics stock.

What is Insider Activity?

What are Summit Therapeutics Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for Summit Therapeutics Inc

Shares Outstanding

775.373M

Shares Float

149360283.0%

Insider Shares Owned

220.960M

Insider Percentage Owned

29.8%

Institutional Shares Held

59.296M

Institutional Percentage Held

7.65%


Oct 23, 2025	Yu Xia	DIRECTOR	533.62K	$18.74	$10.00M	BUY	1.69%	32.06M	Oct 21	View
Oct 23, 2025	Robert W Duggan	CO-CHIEF EXECUTIVE OFFICER	14.27M	$18.74	$267.50M	BUY	∞	10.28M	Oct 21	View
Oct 23, 2025	Mahkam Zanganeh	CO-CHIEF EXECUTIVE OFFICER	14.27M	$18.74	$267.50M	BUY	2.57%	570.10M	Oct 21	View
Sep 11, 2025	Mahkam Zanganeh	CO-CHIEF EXECUTIVE OFFICER	338.39K	$17.69	$5.98M	BUY	0.06%	556.12M	Sep 10 - Sep 11	View
Sep 11, 2025	Robert W Duggan	CO-CHIEF EXECUTIVE OFFICER	338.39K	$17.69	$5.98M	BUY	0.06%	556.14M	Sep 10 - Sep 11	View
Mar 27, 2024	Mahkam Zanganeh	CHIEF EXECUTIVE OFFICER	110.32K	$3.73	$411.09K	BUY	∞	50.00K	Mar 26 - Mar 27	View
Mar 27, 2024	Ankur Dhingra	CHIEF FINANCIAL OFFICER	100.00K	$3.75	$375.00K	BUY	39.22%	354.96K	Mar 26	View
Dec 13, 2023	Mahkam Zanganeh	CHIEF EXECUTIVE OFFICER	810.50K	$1.50	$1.21M	BUY	3.37%	24.89M	Dec 11 - Dec 12	View
Dec 13, 2023	Ankur Dhingra	CHIEF FINANCIAL OFFICER	20.40K	$2.17	$44.25K	BUY	8.70%	254.96K	Dec 13	View
Oct 16, 2023	Manmeet Soni	CHIEF OPERATING OFFICER	2.98M	$1.68	$5.00M	BUY	∞	2.98M	Oct 13	View
Mar 08, 2023	Maky Zanganeh	CO-CHIEF EXECUTIVE OFFICER	23.53M	$1.05	$24.70M	BUY	∞	9.88M	Mar 08	View
Mar 08, 2023	Ankur Dhingra	CHIEF FINANCIAL OFFICER	196.36K	$1.05	$206.18K	BUY	252.64%	274.08K	Mar 07	View
Mar 08, 2023	Robert W Duggan	CHIEF EXECUTIVE OFFICER	376.49M	$1.05	$395.31M	BUY	214.08%	552.35M	Mar 06	View
Aug 18, 2022	Robert W Duggan	CHIEF EXECUTIVE OFFICER	94.85M	$0.97	$92.00M	BUY	140.14%	162.53M	Aug 16	View
Aug 18, 2022	Mahkam Zanganeh	CO-CEO & PRESIDENT	5.81M	$0.97	$5.63M	BUY	∞	3.14M	Aug 16	View
Aug 17, 2022	Ankur Dhingra	CHIEF FINANCIAL OFFICER	36.22K	$0.97	$35.13K	BUY	1828.12%	38.20K	Aug 16	View
May 14, 2021	ROBERT DUGGAN	CHIEF EXECUTIVE OFFICER	11.37M	$5.24	$59.56M	BUY	20.19%	67.66M	May 12	View
May 14, 2021	Mahkam Zanganeh	CHIEF OPERATING OFFICER	389.08K	$5.24	$2.04M	BUY	8.93%	4.75M	May 12	View
Dec 01, 2020	Jonathan David Powell	—	0.00	$3.12	-$111.06K	OPTION EXERCISE	0.00%	0.00	Nov 27 - Nov 30	View
Nov 25, 2020	Jonathan David Powell	—	0.00	$3.11	-$72.34K	OPTION EXERCISE	0.00%	0.00	Nov 23 - Nov 25	View
Nov 10, 2020	ROBERT DUGGAN	—	14.07M	$3.34	$47.00M	PURCHASE	33.33%	56.30M	Nov 06	View

Loading calendar...